In the News: 09/03

Finally, A Cure For RA? Latest results from trials involving tumor necrosis factor (TNF) inhibitors infliximab (Remicade) and etanercept (Enbrel), when used in combination with methotrexate, have rheumotologists talking about the possibility of a cure for rheumatoid arthritis. In one trial, in which infliximab was used with methotrexate to treat patients with early RA, nearly a third of the subjects went into remission. Another trial, conducted with patients with more established RA and using etanercept in…
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access